TY_UPDATA: 2024/12/21
- Home
- Thrombite Clot Retrieval Device Emergent Trial
- About
- Case Report Acute Basilar Artery Occlusion Opening
- Healthcare Professionals
- Case Report Thrombectomy in a patient with atrial fibrillation embolization of the MCA
- Case Report Embolization of C2 Aneurysm of Right Internal Carotid Artery
- Case Report A case of basilar artery occlusion treatment
- Case Report A case of thrombectomy of a large volume thrombus in the ICA
- Case Report A Case of Mechanical Thrombectomy for Atrial Fibrillation-Associated Stroke
- Patients
- News
- Join Us
- Investor Relations
- Announcement & Circulars
- Notice Of Board Meeting
- Announcement Regarding The H Share Full Circulation Listing Approval Granted By The Stock Exchange
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2022
- Voluntary Announcement - Unaudited Operating Statistics For The Year Ended December 31, 2021
- Monthly Return Of Equity Issuer On Movements In Securities For The Month Ended 31 December 2021
- Voluntary Announcement - The Strategic Investment In Wire Sciences
- Monthly Return Of Equity Issuer On Movements In Securities For The Month Ended 30 November 2021
- Voluntary Announcement Completion Of Patient Enrollment For The Flow Diverter Clinical Trial
- Voluntary Announcement Intention Of The Chairman To Increase Shareholding In The Company
- Inside Information Announcement Approval By The Csrc Of The Company's Application For The Full Circulation Of H Shares
- Voluntary Announcement - Collaboration Agreement With Sky Road
- Monthly Return Of Equity Issuer On Movements In Securities For The Month Ended 31 October 2021
- An Announcement Has Just Been Published By The Issuer In The Chinese Section Of This Website, A Corresponding Version Of Which May Or May Not Be Published In This Section
- Monthly Return Of Equity Issuer On Movements In Securities For The Month Ended 30 September 2021
- Notification Letter and Request Form to Non-registered Shareholders
- Interim Report 2021
- Voluntary Announcement National Medical Products Administration Granted Marketing Approval For Neurovascular Embolization Coils In China
- Articles Of Association
- Poll Results Of The 2021 Third Extraordinary General Meeting
- Monthly Return Of Equity Issuer On Movements In Securities For The Month Ended 31 August 2021
- Form Of Proxy For 2021 Third Extraordinary General Meeting
- Notice Of 2021 Third Extraordinary General Meeting
- (1) Proposed Adoption Of The 2021 H Share Award And Trust Scheme; (2) Proposed Authorization To The Board And/or The Delegatee To Handle Matters Pertaining To The 2021 H Share Award And Trust Scheme; (3) Proposed Amendments To The Articles Of Association;
- (1) Proposed Adoption Of The 2021 H Share Award And Trust Scheme; (2) Proposed Authorization To The Board And/or The Delegatee To Handle Matters Pertaining To The 2021 H Share Award And Trust Scheme; (3) Proposed Change Of Registered Address; (4) Proposed
- Interim Results Announcement For The Six Months Ended June 30, 2021
- Notice Of Board Meeting
- Monthly Return Of Equity Issuer On Movements In Securities For The Month Ended 31 July 2021
- Voluntary Announcement Unaudited Operating Statistics For The Period From January 1, 2021 To June 30, 2021
- Next Day Disclosure Return
- Full Exercise Of The Over-allotment Option, Stabilizing Actions And End Of Stabilization Period
- Voluntary Announcement Completion Of Patient Enrollment For The Clinical Trial Of Zynlastic Peripheral Venous Stent System
- List Of Directors And Their Roles And Functions
- Terms Of Reference For The Nomination Committee
- Terms Of Reference For The Remuneration Committee
- Terms Of Reference Of The Audit Committee
- Articles Of Association
- Announcement Of Offer Price And Allotment Results
- Green Application Form
- Global Offering
- Global Offering
- PHIP (1st Submission)
- PHIP (1st Submission)1
- Application Proof (1st Submission)
- Application Proof (1st Submission)
- Voluntary Announcement Unaudited Operating Statistics For The Year Ended December 31, 2021
- Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities
- Announcement Regarding Completion Of The H Share Full Circulation
- Announcement Of Annual Results For The Year Ended December 31, 2021
- Next Day Disclosure Return - July
- Post Hearing Information Pack of Zylox-Tonbridge Medical Technology Co., Ltd.
- Application Proof of Zylox-Tonbridge Medical Technology Co., Ltd.
- Annual Report 2021
- CIRCULAR OF 2021 ANNUAL GENERAL MEETING, 2022 FIRST CLASS MEETING OF HOLDERS OF H SHARES AND 2022 FIRST CLASS MEETING OF HOLDERS OF DOMESTIC SHARES
- NOTICE OF 2021 ANNUAL GENERAL MEETING
- NOTICE OF 2022 FIRST CLASS MEETING OF HOLDERS OF H SHARES
- NOTICE OF 2022 FIRST CLASS MEETING OF HOLDERS OF DOMESTIC SHARES
- FORM OF PROXY FOR 2021 ANNUAL GENERAL MEETING
- FORM OF PROXY FOR 2022 FIRST CLASS MEETING OF HOLDERS OF H SHARES
- FORM OF PROXY FOR 2022 FIRST CLASS MEETING OF HOLDERS OF DOMESTIC SHARES
- VOLUNTARY ANNOUNCEMENT - NATIONAL MEDICAL PRODUCTS ADMINISTRATION GRANTED MARKETING APPROVAL FOR PTA BALLOON CATHETER - LARGE DIAMETER IN CHINA
- VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO THE 2021 H SHARE AWARD AND TRUST SCHEME
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2022
- POLL RESULTS OF THE 2021 ANNUAL GENERAL MEETING, THE 2022 FIRST CLASS MEETING OF HOLDERS OF H SHARES AND 2022 FIRST CLASS MEETING OF HOLDERS OF DOMESTIC SHARES
- LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
- CHANGE OF ADDRESS OF H SHARE REGISTRAR
- UPDATE ANNOUNCEMENT IN RELATION TO THE AMENDMENTS TO THE ARTICLES OF ASSOCIATION
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023
- ARTICLES OF ASSOCIATION
- NOTICE OF BOARD MEETING
- Interim Report 2023
- UPDATE ON QUALIFICATION OF THE JOINT COMPANY SECRETARY
- Prospectus & Financial Report
- Corporate Information
- Presentation Materials
- Financial calendar & Contact
- Contact Us
